{"id":2035,"date":"2019-06-13T20:08:59","date_gmt":"2019-06-13T20:08:59","guid":{"rendered":"https:\/\/entrepreneurship.asu.edu\/blog\/?p=2035"},"modified":"2022-06-01T17:26:21","modified_gmt":"2022-06-01T17:26:21","slug":"asu-startup-has-rasied-25-million-for-commercialization-of-viral-based-therapies","status":"publish","type":"post","link":"https:\/\/entrepreneurship.asu.edu\/blog\/2019\/06\/13\/asu-startup-has-rasied-25-million-for-commercialization-of-viral-based-therapies\/","title":{"rendered":"ASU Startup has rasied $25 million for commercialization of viral-based therapies"},"content":{"rendered":"\n<p>OncoMyx Therapeutics, the latest biotech spinout company from Arizona State University\u2019s Biodesign Institute, announced today it has raised $25 million in new funding to help commercialize an innovative, viral-based therapy for the treatment of cancer.<\/p>\n\n\n\n<p>The announcement marks a major business development milestone for OncoMyx founder, research advisor, and ASU Biodesign scientist&nbsp;<a href=\"https:\/\/isearch.asu.edu\/profile\/3054667\">Grant McFadden<\/a>, a pioneer in a new field called oncolytic virotherapy that can successfully program a virus to infect and kill cancer while leaving normal cells unharmed. See full article <a href=\"https:\/\/asunow.asu.edu\/20190606-oncomyx-therapeutics-invests-bringing-cancer-treatments-market\">here.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"OncoMyx Therapeutics, the latest biotech spinout company from Arizona State University\u2019s Biodesign Institute, announced today it has raised $25 million in new funding to help commercialize an innovative, viral-based therapy","protected":false},"author":24,"featured_media":2032,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"content-type":"","footnotes":""},"categories":[80],"tags":[],"class_list":["post-2035","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"uds_featured_image":{"id":2032,"alt_text":"","caption":"","description":"","media_type":"image","media_details":{"width":965,"height":652,"file":"2019\/06\/StartupEI.jpg","sizes":{"thumbnail":{"file":"StartupEI-150x150.jpg","width":150,"height":150,"mime-type":"image\/jpeg","source_url":"https:\/\/entrepreneurship.asu.edu\/blog\/wp-content\/uploads\/sites\/3\/2019\/06\/StartupEI-150x150.jpg"},"medium":{"file":"StartupEI-300x203.jpg","width":300,"height":203,"mime-type":"image\/jpeg","source_url":"https:\/\/entrepreneurship.asu.edu\/blog\/wp-content\/uploads\/sites\/3\/2019\/06\/StartupEI-300x203.jpg"},"medium_large":{"file":"StartupEI-768x519.jpg","width":768,"height":519,"mime-type":"image\/jpeg","source_url":"https:\/\/entrepreneurship.asu.edu\/blog\/wp-content\/uploads\/sites\/3\/2019\/06\/StartupEI-768x519.jpg"},"post-medium":{"file":"StartupEI-420x284.jpg","width":420,"height":284,"mime-type":"image\/jpeg","source_url":"https:\/\/entrepreneurship.asu.edu\/blog\/wp-content\/uploads\/sites\/3\/2019\/06\/StartupEI-420x284.jpg"},"post-large":{"file":"StartupEI-768x519.jpg","width":768,"height":519,"mime-type":"image\/jpeg","source_url":"https:\/\/entrepreneurship.asu.edu\/blog\/wp-content\/uploads\/sites\/3\/2019\/06\/StartupEI-768x519.jpg"}},"image_meta":{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0","keywords":[]}},"post":2035,"source_url":"https:\/\/entrepreneurship.asu.edu\/blog\/wp-content\/uploads\/sites\/3\/2019\/06\/StartupEI.jpg"},"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ASU Startup has rasied $25 million for commercialization of viral-based therapies - Blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/entrepreneurship.asu.edu\/blog\/2019\/06\/13\/asu-startup-has-rasied-25-million-for-commercialization-of-viral-based-therapies\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ASU Startup has rasied $25 million for commercialization of viral-based therapies - Blog\" \/>\n<meta property=\"og:description\" content=\"OncoMyx Therapeutics, the latest biotech spinout company from Arizona State University\u2019s Biodesign Institute, announced today it has raised $25 million in new funding to help commercialize an innovative, viral-based therapy\" \/>\n<meta property=\"og:url\" content=\"https:\/\/entrepreneurship.asu.edu\/blog\/2019\/06\/13\/asu-startup-has-rasied-25-million-for-commercialization-of-viral-based-therapies\/\" \/>\n<meta property=\"og:site_name\" content=\"Blog\" \/>\n<meta property=\"article:published_time\" content=\"2019-06-13T20:08:59+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-06-01T17:26:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/entrepreneurship.asu.edu\/blog\/wp-content\/uploads\/sites\/3\/2019\/06\/StartupEI.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"965\" \/>\n\t<meta property=\"og:image:height\" content=\"652\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Edson E+I Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Edson E+I Team\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/entrepreneurship.asu.edu\\\/blog\\\/2019\\\/06\\\/13\\\/asu-startup-has-rasied-25-million-for-commercialization-of-viral-based-therapies\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/entrepreneurship.asu.edu\\\/blog\\\/2019\\\/06\\\/13\\\/asu-startup-has-rasied-25-million-for-commercialization-of-viral-based-therapies\\\/\"},\"author\":{\"name\":\"Edson E+I Team\",\"@id\":\"https:\\\/\\\/entrepreneurship.asu.edu\\\/blog\\\/#\\\/schema\\\/person\\\/61c0af0bc9b2d3f17ed6f88a3aa0a1b6\"},\"headline\":\"ASU Startup has rasied $25 million for commercialization of viral-based therapies\",\"datePublished\":\"2019-06-13T20:08:59+00:00\",\"dateModified\":\"2022-06-01T17:26:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/entrepreneurship.asu.edu\\\/blog\\\/2019\\\/06\\\/13\\\/asu-startup-has-rasied-25-million-for-commercialization-of-viral-based-therapies\\\/\"},\"wordCount\":94,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/entrepreneurship.asu.edu\\\/blog\\\/2019\\\/06\\\/13\\\/asu-startup-has-rasied-25-million-for-commercialization-of-viral-based-therapies\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/entrepreneurship.asu.edu\\\/blog\\\/wp-content\\\/uploads\\\/sites\\\/3\\\/2019\\\/06\\\/StartupEI.jpg\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/entrepreneurship.asu.edu\\\/blog\\\/2019\\\/06\\\/13\\\/asu-startup-has-rasied-25-million-for-commercialization-of-viral-based-therapies\\\/\",\"url\":\"https:\\\/\\\/entrepreneurship.asu.edu\\\/blog\\\/2019\\\/06\\\/13\\\/asu-startup-has-rasied-25-million-for-commercialization-of-viral-based-therapies\\\/\",\"name\":\"ASU Startup has rasied $25 million for commercialization of viral-based therapies - Blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/entrepreneurship.asu.edu\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/entrepreneurship.asu.edu\\\/blog\\\/2019\\\/06\\\/13\\\/asu-startup-has-rasied-25-million-for-commercialization-of-viral-based-therapies\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/entrepreneurship.asu.edu\\\/blog\\\/2019\\\/06\\\/13\\\/asu-startup-has-rasied-25-million-for-commercialization-of-viral-based-therapies\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/entrepreneurship.asu.edu\\\/blog\\\/wp-content\\\/uploads\\\/sites\\\/3\\\/2019\\\/06\\\/StartupEI.jpg\",\"datePublished\":\"2019-06-13T20:08:59+00:00\",\"dateModified\":\"2022-06-01T17:26:21+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/entrepreneurship.asu.edu\\\/blog\\\/#\\\/schema\\\/person\\\/61c0af0bc9b2d3f17ed6f88a3aa0a1b6\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/entrepreneurship.asu.edu\\\/blog\\\/2019\\\/06\\\/13\\\/asu-startup-has-rasied-25-million-for-commercialization-of-viral-based-therapies\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/entrepreneurship.asu.edu\\\/blog\\\/2019\\\/06\\\/13\\\/asu-startup-has-rasied-25-million-for-commercialization-of-viral-based-therapies\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/entrepreneurship.asu.edu\\\/blog\\\/2019\\\/06\\\/13\\\/asu-startup-has-rasied-25-million-for-commercialization-of-viral-based-therapies\\\/#primaryimage\",\"url\":\"https:\\\/\\\/entrepreneurship.asu.edu\\\/blog\\\/wp-content\\\/uploads\\\/sites\\\/3\\\/2019\\\/06\\\/StartupEI.jpg\",\"contentUrl\":\"https:\\\/\\\/entrepreneurship.asu.edu\\\/blog\\\/wp-content\\\/uploads\\\/sites\\\/3\\\/2019\\\/06\\\/StartupEI.jpg\",\"width\":965,\"height\":652},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/entrepreneurship.asu.edu\\\/blog\\\/2019\\\/06\\\/13\\\/asu-startup-has-rasied-25-million-for-commercialization-of-viral-based-therapies\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Blog\",\"item\":\"https:\\\/\\\/entrepreneurship.asu.edu\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ASU Startup has rasied $25 million for commercialization of viral-based therapies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/entrepreneurship.asu.edu\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/entrepreneurship.asu.edu\\\/blog\\\/\",\"name\":\"Blog\",\"description\":\"Edson E+I\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/entrepreneurship.asu.edu\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/entrepreneurship.asu.edu\\\/blog\\\/#\\\/schema\\\/person\\\/61c0af0bc9b2d3f17ed6f88a3aa0a1b6\",\"name\":\"Edson E+I Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/72cfedb2bee53a3ab9f2bc89b014d5edf1295a157e581d514ccd061f3f4eb7fd?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/72cfedb2bee53a3ab9f2bc89b014d5edf1295a157e581d514ccd061f3f4eb7fd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/72cfedb2bee53a3ab9f2bc89b014d5edf1295a157e581d514ccd061f3f4eb7fd?s=96&d=mm&r=g\",\"caption\":\"Edson E+I Team\"},\"url\":\"https:\\\/\\\/entrepreneurship.asu.edu\\\/blog\\\/author\\\/ei-team\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ASU Startup has rasied $25 million for commercialization of viral-based therapies - Blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/entrepreneurship.asu.edu\/blog\/2019\/06\/13\/asu-startup-has-rasied-25-million-for-commercialization-of-viral-based-therapies\/","og_locale":"en_US","og_type":"article","og_title":"ASU Startup has rasied $25 million for commercialization of viral-based therapies - Blog","og_description":"OncoMyx Therapeutics, the latest biotech spinout company from Arizona State University\u2019s Biodesign Institute, announced today it has raised $25 million in new funding to help commercialize an innovative, viral-based therapy","og_url":"https:\/\/entrepreneurship.asu.edu\/blog\/2019\/06\/13\/asu-startup-has-rasied-25-million-for-commercialization-of-viral-based-therapies\/","og_site_name":"Blog","article_published_time":"2019-06-13T20:08:59+00:00","article_modified_time":"2022-06-01T17:26:21+00:00","og_image":[{"width":965,"height":652,"url":"https:\/\/entrepreneurship.asu.edu\/blog\/wp-content\/uploads\/sites\/3\/2019\/06\/StartupEI.jpg","type":"image\/jpeg"}],"author":"Edson E+I Team","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Edson E+I Team"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/entrepreneurship.asu.edu\/blog\/2019\/06\/13\/asu-startup-has-rasied-25-million-for-commercialization-of-viral-based-therapies\/#article","isPartOf":{"@id":"https:\/\/entrepreneurship.asu.edu\/blog\/2019\/06\/13\/asu-startup-has-rasied-25-million-for-commercialization-of-viral-based-therapies\/"},"author":{"name":"Edson E+I Team","@id":"https:\/\/entrepreneurship.asu.edu\/blog\/#\/schema\/person\/61c0af0bc9b2d3f17ed6f88a3aa0a1b6"},"headline":"ASU Startup has rasied $25 million for commercialization of viral-based therapies","datePublished":"2019-06-13T20:08:59+00:00","dateModified":"2022-06-01T17:26:21+00:00","mainEntityOfPage":{"@id":"https:\/\/entrepreneurship.asu.edu\/blog\/2019\/06\/13\/asu-startup-has-rasied-25-million-for-commercialization-of-viral-based-therapies\/"},"wordCount":94,"commentCount":0,"image":{"@id":"https:\/\/entrepreneurship.asu.edu\/blog\/2019\/06\/13\/asu-startup-has-rasied-25-million-for-commercialization-of-viral-based-therapies\/#primaryimage"},"thumbnailUrl":"https:\/\/entrepreneurship.asu.edu\/blog\/wp-content\/uploads\/sites\/3\/2019\/06\/StartupEI.jpg","articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/entrepreneurship.asu.edu\/blog\/2019\/06\/13\/asu-startup-has-rasied-25-million-for-commercialization-of-viral-based-therapies\/","url":"https:\/\/entrepreneurship.asu.edu\/blog\/2019\/06\/13\/asu-startup-has-rasied-25-million-for-commercialization-of-viral-based-therapies\/","name":"ASU Startup has rasied $25 million for commercialization of viral-based therapies - Blog","isPartOf":{"@id":"https:\/\/entrepreneurship.asu.edu\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/entrepreneurship.asu.edu\/blog\/2019\/06\/13\/asu-startup-has-rasied-25-million-for-commercialization-of-viral-based-therapies\/#primaryimage"},"image":{"@id":"https:\/\/entrepreneurship.asu.edu\/blog\/2019\/06\/13\/asu-startup-has-rasied-25-million-for-commercialization-of-viral-based-therapies\/#primaryimage"},"thumbnailUrl":"https:\/\/entrepreneurship.asu.edu\/blog\/wp-content\/uploads\/sites\/3\/2019\/06\/StartupEI.jpg","datePublished":"2019-06-13T20:08:59+00:00","dateModified":"2022-06-01T17:26:21+00:00","author":{"@id":"https:\/\/entrepreneurship.asu.edu\/blog\/#\/schema\/person\/61c0af0bc9b2d3f17ed6f88a3aa0a1b6"},"breadcrumb":{"@id":"https:\/\/entrepreneurship.asu.edu\/blog\/2019\/06\/13\/asu-startup-has-rasied-25-million-for-commercialization-of-viral-based-therapies\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/entrepreneurship.asu.edu\/blog\/2019\/06\/13\/asu-startup-has-rasied-25-million-for-commercialization-of-viral-based-therapies\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/entrepreneurship.asu.edu\/blog\/2019\/06\/13\/asu-startup-has-rasied-25-million-for-commercialization-of-viral-based-therapies\/#primaryimage","url":"https:\/\/entrepreneurship.asu.edu\/blog\/wp-content\/uploads\/sites\/3\/2019\/06\/StartupEI.jpg","contentUrl":"https:\/\/entrepreneurship.asu.edu\/blog\/wp-content\/uploads\/sites\/3\/2019\/06\/StartupEI.jpg","width":965,"height":652},{"@type":"BreadcrumbList","@id":"https:\/\/entrepreneurship.asu.edu\/blog\/2019\/06\/13\/asu-startup-has-rasied-25-million-for-commercialization-of-viral-based-therapies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Blog","item":"https:\/\/entrepreneurship.asu.edu\/blog\/"},{"@type":"ListItem","position":2,"name":"ASU Startup has rasied $25 million for commercialization of viral-based therapies"}]},{"@type":"WebSite","@id":"https:\/\/entrepreneurship.asu.edu\/blog\/#website","url":"https:\/\/entrepreneurship.asu.edu\/blog\/","name":"Blog","description":"Edson E+I","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/entrepreneurship.asu.edu\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/entrepreneurship.asu.edu\/blog\/#\/schema\/person\/61c0af0bc9b2d3f17ed6f88a3aa0a1b6","name":"Edson E+I Team","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/72cfedb2bee53a3ab9f2bc89b014d5edf1295a157e581d514ccd061f3f4eb7fd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/72cfedb2bee53a3ab9f2bc89b014d5edf1295a157e581d514ccd061f3f4eb7fd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/72cfedb2bee53a3ab9f2bc89b014d5edf1295a157e581d514ccd061f3f4eb7fd?s=96&d=mm&r=g","caption":"Edson E+I Team"},"url":"https:\/\/entrepreneurship.asu.edu\/blog\/author\/ei-team\/"}]}},"uds_news_author":null,"uds_story_hero":{"background_choice":"image","background_color":null,"background_image":{"ID":2032,"id":2032,"title":"StartupE+I","filename":"StartupEI.jpg","filesize":74526,"url":"https:\/\/entrepreneurship.asu.edu\/blog\/wp-content\/uploads\/sites\/3\/2019\/06\/StartupEI.jpg","link":"https:\/\/entrepreneurship.asu.edu\/blog\/2019\/06\/13\/asu-startup-has-rasied-25-million-for-commercialization-of-viral-based-therapies\/startupei\/","alt":"","author":"24","description":"","caption":"","name":"startupei","status":"inherit","uploaded_to":2035,"date":"2019-06-12 03:56:46","modified":"2022-06-01 17:26:22","menu_order":0,"mime_type":"image\/jpeg","type":"image","subtype":"jpeg","icon":"https:\/\/entrepreneurship.asu.edu\/blog\/wp-includes\/images\/media\/default.png","width":965,"height":652,"sizes":{"thumbnail":"https:\/\/entrepreneurship.asu.edu\/blog\/wp-content\/uploads\/sites\/3\/2019\/06\/StartupEI-150x150.jpg","thumbnail-width":150,"thumbnail-height":150,"medium":"https:\/\/entrepreneurship.asu.edu\/blog\/wp-content\/uploads\/sites\/3\/2019\/06\/StartupEI-300x203.jpg","medium-width":300,"medium-height":203,"medium_large":"https:\/\/entrepreneurship.asu.edu\/blog\/wp-content\/uploads\/sites\/3\/2019\/06\/StartupEI-768x519.jpg","medium_large-width":640,"medium_large-height":433,"large":"https:\/\/entrepreneurship.asu.edu\/blog\/wp-content\/uploads\/sites\/3\/2019\/06\/StartupEI.jpg","large-width":640,"large-height":432,"1536x1536":"https:\/\/entrepreneurship.asu.edu\/blog\/wp-content\/uploads\/sites\/3\/2019\/06\/StartupEI.jpg","1536x1536-width":965,"1536x1536-height":652,"2048x2048":"https:\/\/entrepreneurship.asu.edu\/blog\/wp-content\/uploads\/sites\/3\/2019\/06\/StartupEI.jpg","2048x2048-width":965,"2048x2048-height":652,"gform-image-choice-sm":"https:\/\/entrepreneurship.asu.edu\/blog\/wp-content\/uploads\/sites\/3\/2019\/06\/StartupEI.jpg","gform-image-choice-sm-width":300,"gform-image-choice-sm-height":203,"gform-image-choice-md":"https:\/\/entrepreneurship.asu.edu\/blog\/wp-content\/uploads\/sites\/3\/2019\/06\/StartupEI.jpg","gform-image-choice-md-width":400,"gform-image-choice-md-height":270,"gform-image-choice-lg":"https:\/\/entrepreneurship.asu.edu\/blog\/wp-content\/uploads\/sites\/3\/2019\/06\/StartupEI.jpg","gform-image-choice-lg-width":600,"gform-image-choice-lg-height":405}},"background_image_size":"medium"},"_links":{"self":[{"href":"https:\/\/entrepreneurship.asu.edu\/blog\/wp-json\/wp\/v2\/posts\/2035","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/entrepreneurship.asu.edu\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/entrepreneurship.asu.edu\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/entrepreneurship.asu.edu\/blog\/wp-json\/wp\/v2\/users\/24"}],"replies":[{"embeddable":true,"href":"https:\/\/entrepreneurship.asu.edu\/blog\/wp-json\/wp\/v2\/comments?post=2035"}],"version-history":[{"count":0,"href":"https:\/\/entrepreneurship.asu.edu\/blog\/wp-json\/wp\/v2\/posts\/2035\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/entrepreneurship.asu.edu\/blog\/wp-json\/wp\/v2\/media\/2032"}],"wp:attachment":[{"href":"https:\/\/entrepreneurship.asu.edu\/blog\/wp-json\/wp\/v2\/media?parent=2035"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/entrepreneurship.asu.edu\/blog\/wp-json\/wp\/v2\/categories?post=2035"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/entrepreneurship.asu.edu\/blog\/wp-json\/wp\/v2\/tags?post=2035"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}